Allergan COVID-19 Response: Program Enhancements

Source: Allergan
Allergan has announced several program enhancements designed to assist eye care professionals and patients during the COVID-19 pandemic. These include:
  • Lowering copay savings card offerings for Restasis, Restasis Multidose, Lumigan, Combigan, and Alphagan P
  • Beginning April 1, 2020 through May 31, 2020, eligible commercially insured patients* will pay as little as $0 using the My Tears, My Rewards, or At Your Service programs – patients can enroll at restasis.com or savewithays.com 
    • *Note: This limited-time offer is not valid for patients enrolled in Medicare, Medicaid, a Medicare drug benefit plan, TRICARE, or other federal or state health programs such as medical assistance programs; other limitations may apply
  • Increasing the coupon value on all Refresh products from $4 to $10. Patients can visit RefreshRewards.com for their coupon
  • Extending additional payment terms for products purchased directly from Allergan, specifically Ozurdex and Xen, on or before March 23
Additionally, the Refresh brand has donated $250,000 to DirectRelief to support their ongoing COVID-19 emergency relief efforts, as part of the Refresh America program. 

Related Content